论文部分内容阅读
胰岛素抵抗(insulinresistance,RI)是2型糖尿病发病的重要机制之一[1]。早已证实短效的磺脲类药物能改善RI,但因服用次数多难被患者接受[2]。我们旨在探讨格列比嗪控释片作为一种短效而又减少服药次数的新剂型磺脲类药物对糖尿病患者胰岛素抵抗的影响。材料和方法1.所选对象均
Insulin resistance (insulin resistance, RI) is one of the important pathogenesis of type 2 diabetes [1]. Short-acting sulfonylureas have long been shown to improve RI but are harder to be accepted by patients [2]. We aimed to investigate the effect of glipizide as a short-acting and less-administered new-type sulfonylurea on insulin resistance in diabetic patients. Materials and methods 1. All selected objects